Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Doshi Dipal Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 1,000 shares @ $15.6713, valued at $15.7k
05/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2023 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,000 shares @ $12, valued at $24k
01/30/2023 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,000 shares @ $12.0005, valued at $24k
01/10/2023 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,410 shares @ $15.0189, valued at $36.2k
12/29/2022 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 600 shares @ $14.7989, valued at $8.9k
Sold 9,069 shares @ $15.0384, valued at $136.4k
Sold 4,521 shares @ $15.0081, valued at $67.9k
Sold 400 shares @ $15.0128, valued at $6k
11/30/2022 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 2,000 shares @ $13.9131, valued at $27.8k
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/23/2022 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 3,402 shares @ $15.1162, valued at $51.4k
Sold 1,023 shares @ $15.066, valued at $15.4k
09/19/2022 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Sold 200 shares @ $15.04, valued at $3k
09/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Granted 30,250 shares @ $0
Granted 181,500 options to buy @ $11.57, valued at $2.1M
01/18/2022 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Exercised 10,000 options to buy @ $1.74, valued at $17.4k
11/01/2021 4 Doshi Dipal (President and CEO) has filed a Form 4 on Entrada Therapeutics, Inc.
Txns: Granted 184,821 options to buy @ $20, valued at $3.7M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy